Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 366-49-4 | MDL No. : | MFCD00045064 |
Formula : | C9H10FNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OSXGBILCTZUOGO-UHFFFAOYSA-N |
M.W : | 167.18 | Pubchem ID : | 3523118 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.68 |
TPSA : | 29.1 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.4 cm/s |
Log Po/w (iLOGP) : | 1.95 |
Log Po/w (XLOGP3) : | 1.29 |
Log Po/w (WLOGP) : | 2.32 |
Log Po/w (MLOGP) : | 2.27 |
Log Po/w (SILICOS-IT) : | 2.26 |
Consensus Log Po/w : | 2.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.93 |
Solubility : | 1.98 mg/ml ; 0.0118 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.5 |
Solubility : | 5.28 mg/ml ; 0.0316 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.44 |
Solubility : | 0.0601 mg/ml ; 0.00036 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.25 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 326-65-8 ]
N-(4-Fluoro-2-methylphenyl)acetamide
Similarity: 0.96
[ 322-33-8 ]
N-(3-Fluoro-2-methylphenyl)acetamide
Similarity: 0.94
[ 1046757-31-6 ]
2-Amino-N-(5-fluoro-2-methylphenyl)acetamide hydrochloride
Similarity: 0.90
[ 85817-59-0 ]
2-Chloro-N-(5-fluoro-2-methylphenyl)acetamide
Similarity: 0.88
[ 366-48-3 ]
N-(5-Fluoro-2-methylphenyl)formamide
Similarity: 0.86
[ 326-65-8 ]
N-(4-Fluoro-2-methylphenyl)acetamide
Similarity: 0.96
[ 322-33-8 ]
N-(3-Fluoro-2-methylphenyl)acetamide
Similarity: 0.94
[ 1046757-31-6 ]
2-Amino-N-(5-fluoro-2-methylphenyl)acetamide hydrochloride
Similarity: 0.90
[ 85817-59-0 ]
2-Chloro-N-(5-fluoro-2-methylphenyl)acetamide
Similarity: 0.88
[ 366-48-3 ]
N-(5-Fluoro-2-methylphenyl)formamide
Similarity: 0.86
[ 326-65-8 ]
N-(4-Fluoro-2-methylphenyl)acetamide
Similarity: 0.96
[ 322-33-8 ]
N-(3-Fluoro-2-methylphenyl)acetamide
Similarity: 0.94
[ 1046757-31-6 ]
2-Amino-N-(5-fluoro-2-methylphenyl)acetamide hydrochloride
Similarity: 0.90
[ 85817-59-0 ]
2-Chloro-N-(5-fluoro-2-methylphenyl)acetamide
Similarity: 0.88
[ 1147192-77-5 ]
3-Amino-N-(5-fluoro-2-methylphenyl)propanamide hydrochloride
Similarity: 0.86
[ 326-65-8 ]
N-(4-Fluoro-2-methylphenyl)acetamide
Similarity: 0.96
[ 322-33-8 ]
N-(3-Fluoro-2-methylphenyl)acetamide
Similarity: 0.94
[ 1046757-31-6 ]
2-Amino-N-(5-fluoro-2-methylphenyl)acetamide hydrochloride
Similarity: 0.90
[ 85817-59-0 ]
2-Chloro-N-(5-fluoro-2-methylphenyl)acetamide
Similarity: 0.88
[ 366-48-3 ]
N-(5-Fluoro-2-methylphenyl)formamide
Similarity: 0.86